Deprince Race & Zollo Inc Pfizer Inc Transaction History

Deprince Race & Zollo Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $5.4 Million - $6.16 Million	-140,399 Reduced 23.85%	448,359 $19.6 Million
Q3 2018 Oct 15, 2018	SELL	$34.47 - $41.81 $3.71 Million - $4.5 Million	-107,728 Reduced 15.47%	588,758 $25.9 Million
Q2 2018 Jul 17, 2018	SELL	$32.98 - $35.16 $396,716 - $422,939	-12,029 Reduced 1.7%	696,486 $25.3 Million
Q1 2018 Apr 18, 2018	BUY	$31.91 - $37.02 $918,816 - $1.07 Million	28,794 Added 4.24%	708,515 $25.1 Million
Q4 2017 Jan 26, 2018	SELL	$33.26 - $35.29 $1.81 Million - $1.92 Million	-54,310 Reduced 7.4%	679,721 $24.6 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $22.8 Million - $25.1 Million	734,031	734,031 $26.2 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

Stay updated on Deprince Race & Zollo Inc with notifications on news.